Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Physiology - Gastrointestinal and Liver Physiology

• Publication date

  2012-09-15

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1152/ajpgi.00152.2012PMID 22821944PMCID PMC3468538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy

  2012cited by this paper
• Functional analysis of colonic bacterial metabolism: relevant to health?

  2012cited by this paper
• Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis

  2012cited by this paper
• 116 THE GUT MICROBIOME MODULATES FECAL BILE ACID PROFILE IN PATIENTS WITH CIRRHOSIS

  2012cited by this paper
• Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense

  2012cited by this paper
• Linkage of gut microbiome with cognition in hepatic encephalopathy.

  2012cited by this paper
• Comparison of the Gut Microbe Profiles and Numbers Between Patients with Liver Cirrhosis and Healthy Individuals

  2012cited by this paper
• Colonic microbiome is altered in alcoholism.

  2012cited by this paper
• Effects of Bifidobacterium breve on inflammatory gene expression in neonatal and weaning rat intestine

  2012cited by this paper
• Diversity of the autochthonous colonic microbiota

  2011cited by this paper
• New assessment of hepatic encephalopathy.

  2011cited by this paper
• Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.

  2011cited by this paper
• Characterization of fecal microbial communities in patients with liver cirrhosis

  2011cited by this paper
• Metagenomic biomarker discovery and explanation

  2011cited by this paper
• Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.

  2011cited by this paper
• Gut Microbiota and Inflammation

  2011cited by this paper
• Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species

  2011cited by this paper
• The Gut's Clostridium Cocktail

  2011cited by this paper
• Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis

  2011cited by this paper
• Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells

  2010cited by this paper
• Quantitative Assessment of the Human Gut Microbiome Using Multitag Pyrosequencing

  2010cited by this paper
• Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians

  2010cited by this paper
• Cirrhotic patients are at risk for health care-associated bacterial infections.

  2010cited by this paper
• Peripheral and Splanchnic Indole and Oxindole Levels in Cirrhotic Patients: A Study on the Pathophysiology of Hepatic Encephalopathy

  2010cited by this paper
• Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed?

  2010cited by this paper
• Targeting IL-23 in human diseases

  2010cited by this paper
• Checks and balances: IL-23 in the intestine.

  2010cited by this paper
• Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine.

  2009cited by this paper
• Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples

  2009cited by this paper
• The Bifidobacterium dentium Bd1 Genome Sequence Reflects Its Genetic Adaptation to the Human Oral Cavity

  2009cited by this paper
• Plant Cell Wall Breakdown by Anaerobic Microorganisms from the Mammalian Digestive Tract

  2008cited by this paper
• Bacterial infections, sepsis, and multiorgan failure in cirrhosis.

  2008cited by this paper
• Analysis of bacterial bowel communities of IBD patients: What has it revealed?

  2008cited by this paper
• The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria

  2008cited by this paper
• Inhibitory control test for the diagnosis of minimal hepatic encephalopathy.

  2008cited by this paper
• Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

  2008cited by this paper
• Role of ammonia and inflammation in minimal hepatic encephalopathy

  2007cited by this paper
• Tablas de normalidad de la población española para los tests psicométricos utilizados en el diagnóstico de la encefalopatía hepática mínima

  2006cited by this paper
• Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor.

  2006cited by this paper
• Molecular characterization of the bacteria adherent to human colorectal mucosa

  2006cited by this paper
• How bile acids confer gut mucosal protection against bacteria.

  2006cited by this paper
• [Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy].

  2006cited by this paper
• Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club

  2005cited by this paper
• UniFrac: a New Phylogenetic Method for Comparing Microbial Communities

  2005cited by this paper
• Bacterial translocation (BT) in cirrhosis

  2005cited by this paper
• Development of methods for the detection and quantification of 7alpha-dehydroxylating clostridia, Desulfovibrio vulgaris, Methanobrevibacter smithii, and Lactobacillus plantarum in human feces.

  2005cited by this paper
• Biodiversity of the Mucosa‐Associated Microbiota Is Stable Along the Distal Digestive Tract in Healthy Individuals and Patients With Ibd

  2005cited by this paper
• Lactulose ingestion increases faecal bifidobacterial counts: A randomised double-blind study in healthy humans

  2004cited by this paper
• Principal Component Analysis

  2002cited by this paper
• Mucosa-Associated Bacteria in the Human Gastrointestinal Tract Are Uniformly Distributed along the Colon and Differ from the Community Recovered from Feces

  2002cited by this paper
• A model to predict survival in patients with end‐stage liver disease

  2001cited by this paper
• Neuropsychological characterization of hepatic encephalopathy.

  2001cited by this paper
• Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut

  2000cited by this paper
• Elevated Serum Levels of Astroglial S100β in Patients with Liver Cirrhosis Indicate Early and Subclinical Portal-Systemic Encephalopathy

  1999cited by this paper
• 16S/23S rRNA sequencing

  1991cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Gut mucosal mycobiome profiling in Crohn’s disease uncovers an AMP-mediated anti-inflammatory effect of Cladosporium sphaerospermum

  2026cites this paper
• Metataxonomic Analysis and Fatty Acid Profiling of Feces from Children Undergoing Hematopoietic Stem Cell Transplantation

  2026cites this paper
• Probiotic or synbiotic interventions and chemotherapy-associated diarrhea in cancer patients: a meta-analysis of randomized trials

  2026cites this paper
• Current advances in the management of hepatic encephalopathy: an updated and critical review

  2025cites this paper
• Latroeggtoxin-VI improves depression by regulating the composition and function of gut microbiota in a mouse model of depression

  2025cites this paper
• New insights into gut-liver axis in advanced liver diseases: A promising therapeutic target.

  2025cites this paper
• Ammonia and beyond – biomarkers of hepatic encephalopathy

  2025cites this paper
• A Systematic Review of Microbiota in Cirrhosis: A Change Towards a More Pathogenic Predisposition

  2025cites this paper
• Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation

  2025cites this paper
• A Review of Recent Advances in Fecal Microbiota Transplantation for the Treatment of Hepatic Encephalopathy

  2025cites this paper
• Gut microbiome composition in patients with liver cirrhosis with and without hepatic encephalopathy: A systematic review and meta-analysis

  2025cites this paper
• Role of the intestinal microbiota in sepsis-associated encephalopathy

  2025cites this paper
• Relationship between fecal microbiota and daily dietary macronutrient intake in male and female patients with hepatitis C virus-cirrhosis: A pilot study.

  2025cites this paper
• Understanding crosstalk between the gut and liver microbiome: pathogenesis to therapeutic approaches in liver cancer

  2025cites this paper
• Mucosal microbiota signatures reveal diagnostic insights in chronic liver disease

  2025cites this paper
• Proteus spp.—taxonomy, clinical significance, and antibiotic resistance of a highly versatile pathogen

  2025cites this paper
• Can the use of synbiotics following live donor liver transplantation alter the microbiota milieu, decrease infection rates and improve graft survival?

  2025cites this paper
• Gut Microbiota and the Gut–Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies

  2025cites this paper
• Leveraging the gut microbiome to understand the risk factor of cognitive impairment in patients with liver cirrhosis

  2025cites this paper
• Hepatic Steatosis and Microbiota: A Regional Study on Patients from Western Romania

  2025cites this paper
• Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota

  2025cites this paper
• Fecal carriage of multidrug-resistant organisms increases the risk of hepatic encephalopathy in patients with cirrhosis: insights from gut microbiota and metabolite features

  2025cites this paper
• Kin Recognition Systems and Their Role in Multicellular Behaviors.

  2025cites this paper
• Influence of creatine pyruvate on newly received cattle: insights from metagenomics and metabolomics

  2025cites this paper
• Study of gut microbiota in cholangiocarcinoma patients

  2025cites this paper
• The nisin O cluster: species dissemination, candidate leader peptide proteases and the role of regulatory systems

  2025cites this paper
• Lactiplantibacillus plantarum Lp05 protects against ethanol-induced liver injury in zebrafish through metabolic and microbiota modulation

  2025cites this paper
• Amazake (Japanese fermented rice beverage) and its potential health benefits

  2025cites this paper
• Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023)

  2024cites this paper
• Dietary Supplementation with Bupleuri Radix Reduces Oxidative Stress Occurring during Growth by Regulating Rumen Microbes and Metabolites

  2024cites this paper
• Exploring the complex interplay: gut microbiome, stress, and leptospirosis

  2024cites this paper
• Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients

  2024cites this paper
• Chronic Liver Disease and Promising Therapeutic Strategy: A Concise Review

  2024cites this paper
• Virological response to nucleos(t)ide analogues treatment in chronic hepatitis B patients is associated with Bacteroides-dominant gut microbiome

  2024cites this paper
• Rifaximin treatment shapes a unique metagenome‐metabolism network in patients with decompensated cirrhosis

  2024cites this paper
• Fecal microbiota transplant in liver diseases: Current evidence and future directions.

  2024cites this paper
• Fecal Carriage of Multidrug-Resistant Organisms Increases the Risk of Hepatic Encephalopathy in Cirrhotic Patients: Insights from Gut Microbiota and Metabolite Features

  2024cites this paper
• Liver and Brain Disorders

  2024cites this paper
• Intermittent fasting, calorie restriction, and a ketogenic diet improve mitochondrial function by reducing lipopolysaccharide signaling in monocytes during obesity: A randomized clinical trial.

  2024cites this paper
• Assessing the causal association between sleep apnea and the human gut microbiome composition: A two-sample Mendelian randomization study

  2024cites this paper
• MODULATION OF GUT MICROBIOTA THROUGH PHYSICAL ACTIVITY IN INDIVIDUALS WITH OBESITY - A SYSTEMATIC REVIEW.

  2024cites this paper
• A study on the relationship between gut microbiota and intrahepatic cholestasis of pregnancy

  2024cites this paper
• The future of clinical trials of gut microbiome therapeutics in cirrhosis

  2024cites this paper
• Secondary analysis reveals gut microbiota differences in patients with Parkinson’s disease and/or cognitive impairment

  2024cites this paper
• Looking at the full picture, using topic modeling to observe microbiome communities associated with disease.

  2024cites this paper
• Cholelithiasis, Gut Microbiota and Bile Acids after Bariatric Surgery—Can Cholelithiasis Be Prevented by Modulating the Microbiota? A Literature Review

  2024cites this paper
• Gut‑liver axis in liver disease: From basic science to clinical treatment (Review)

  2024cites this paper
• Blackcurrants shape gut microbiota profile and reduce risk of postmenopausal osteoporosis via the gut-bone axis: Evidence from a pilot randomized controlled trial.

  2024cites this paper
• Association Between Gut Microbiota and Gastric Ulcer: A Two-Sample Mendelian Randomization Study

  2024cites this paper
• Exploring the impact of gut microbiota on liver health in mice and patients with Wilson disease

  2024cites this paper
• Microbiota-gut-liver-brain axis and hepatic encephalopathy

  2024cites this paper
• Therapeutic benefit of probiotic in alcohol dependence syndrome: Evidence from a tertiary care centre of India.

  2024cites this paper
• Gut microbiome composition and metabolic activity in women with diverticulitis

  2024cites this paper
• Viral Liver Disease and Intestinal Gut–Liver Axis

  2024cites this paper
• From Cirrhosis to the Dysbiosis (A Loop of Cure or Complications?)

  2024cites this paper
• Neuroimmune modulation in liver pathophysiology

  2024cites this paper
• Gut microbiota and dynamics of ammonia metabolism in liver disease

  2024cites this paper
• Gut–Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers

  2024cites this paper
• Big Data in Gastroenterology Research

  2023cites this paper
• Gut Microbiota of the Asian-Indian Type 2 Diabetes Phenotype: How Different It Is from the Rest of the World?

  2023cites this paper
• Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease

  2023cites this paper
• Effects of neutral polysaccharide from Platycodon grandiflorum on high-fat diet-induced obesity via the regulation of gut microbiota and metabolites

  2023cites this paper
• Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis

  2023cites this paper
• Gut microbiota might influence the risk of rejection after liver transplantation

  2023cites this paper
• Intestinal dysbiosis and probiotic use: its place in hepatic encephalopathy in cirrhosis

  2023cites this paper
• Intestinal microbiota protects against methylmercury-induced neurotoxicity

  2023cites this paper
• Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis

  2023cites this paper
• Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease

  2023influential citation
• Alterations of the gut microbiota in patients with postherpetic neuralgia

  2023cites this paper
• The causality between gut microbiome and liver cirrhosis: a bi-directional two-sample Mendelian randomization analysis

  2023cites this paper
• Association between post-stroke cognitive impairment and gut microbiota: A PRISMA-compliant systematic review and meta-analysis

  2023cites this paper
• Looking at the Full Picture: Utilizing Topic Modeling to Determine Disease-Associated Microbiome Communities

  2023cites this paper
• Regional changes in intestinal permeability in cirrhosis are associated with mucosal bacteria

  2023cites this paper
• Prebiotic activity of lactulose optimizes gut metabolites and prevents systemic infection in liver disease patients

  2023cites this paper
• Microbiome and Genetic Factors in the Pathogenesis of Liver Diseases

  2023cites this paper
• Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease

  2023cites this paper
• The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis

  2023cites this paper
• Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders

  2023cites this paper
• Hepatic Encephalopathy in Acute-on-Chronic Liver Failure.

  2023cites this paper
• Hyperammonemia induced gut microbiota dysbiosis and motor coordination disturbances in mice: new insight into gut‑brain axis involvement in hepatic encephalopathy.

  2023influential citation
• Gut microbiota and its relation to inflammation in patients with bipolar depression: a cross-sectional study

  2023cites this paper
• The hindgut microbiome contributes to host oxidative stress in postpartum dairy cows by affecting glutathione synthesis process

  2023cites this paper
• Changes in the gut microbiome in the first two years of life predicted the temperament in toddlers.

  2023cites this paper
• The shaping of gut immunity in cirrhosis

  2023cites this paper
• Intestinal mucin-type O-glycans: the major players in the host-bacteria-rotavirus interactions

  2023cites this paper
• Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis

  2023cites this paper
• Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain

  2023cites this paper
• Barley Leaf Ameliorates Citrobacter-rodentium-Induced Colitis through Arginine Enrichment

  2023cites this paper
• Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of Hepatology.

  2023cites this paper
• Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database

  2023cites this paper
• Integrated analysis of metabolomic and transcriptomic profiling reveals the effect of Buyang Huanwu decoction on Parkinson's disease in mice.

  2023cites this paper
• Unique trans-kingdom microbiome structural and functional signatures predict cognitive decline in older adults

  2023cites this paper
• Effects of common plastic products heat exposure on cognition: Mediated by gut microbiota.

  2023cites this paper
• Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy

  2023cites this paper
• Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease

  2023cites this paper
• Hepatic Encephalopathy: Diagnostic Tools and Management Strategies.

  2023cites this paper
• Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer

  2023cites this paper
• Gut microbiome-brain-cirrhosis axis.

  2023cites this paper
• From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes

  2023cites this paper
• Hepatic encephalopathy – recent advances in treatment and diagnosis

  2023cites this paper